Trial intelligence / Profile preview

Vitamin D and vascular health in type 2 diabetes

2005-003615-70Phase 4Completed

Sponsor
University of Dundee
Start
Aug 2005
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of vitamin d in type 2 diabetes mellitus (T2DM), endothelial dysfunction and arteriosclerosis, sponsored by University of Dundee. Primary endpoint: Endothelial function measured by flow-mediated dilatation of the brachial artery. Started Aug 2005; status: completed.

02

Drugs

vitamin d
03

Conditions

type 2 diabetes mellitus (T2DM)endothelial dysfunctionarteriosclerosis

Beyond the preview

Go deeper on 2005-003615-70.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003615-70.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call